While we are waiting for FDA decision on Ryoncil, it'd be nice if the company clears up some questions:
1. Do we have a hard date on pre-BLA meeting on heart?
2. How does the company intend to extend its cash runway if approval doesn't come by Jan 25 or (worst case scenario) doesn't come at all?
3. Can they spill some more beans in relation to the "active discussions" with the FDA regarding the BLA review?
I'd like to know more information on what odds I'm playing in this gamble of my life.
While we are waiting for FDA decision on Ryoncil, it'd be nice...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
-0.010(1.08%) |
Mkt cap ! $1.044B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 94.0¢ | 91.5¢ | $1.609M | 1.737M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 131951 | 91.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 22000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |